4//SEC Filing
Martin Tami Tillotson 4
Accession 0001104659-23-026085
CIK 0001356576other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:03 PM ET
Size
8.5 KB
Accession
0001104659-23-026085
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Restricted Stock Units
2023-02-23+5,000→ 5,000 total→ Common Stock (5,000 underlying) - Award
Employee Stock Option (Right to Buy)
2023-02-23+20,000→ 20,000 totalExercise: $38.60Exp: 2033-02-23→ Common Stock (20,000 underlying)
Holdings
- 90,323
Common Stock
Footnotes (3)
- [F1]The option vests in four equal annual installments beginning on February 23, 2024.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:03 PM ET
- Size
- 8.5 KB